In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...
Trump's pick for HHS Secretary faces questions from the left and right over his health stances. But will that stop his ...
The parents of a young Wisconsin man have sued Walgreens and pharmacy benefit manager OptumRx over their son’s death from an ...
The Senate Finance Committee holds Health and Human Services secretary nominee Robert F. Kennedy Jr.'s first confirmation ...
According to Bloomberg, a top Cigna executive said it will prevent patients from paying the full list price for drugs, or more than their employer has contributed.